Current status of bevacizumab in advanced ovarian cancer

Ovarian cancer is the most lethal gynecological cancer, mainly because of the delay in diagnosis. Recently, much effort has been put into investigating and introducing novel targeted agents into clinical practice, with the aim of improving prognosis and quality of life. Angiogenesis is a possible ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomao, Federica, Papa, Anselmo, Rossi, Luigi, Caruso, Davide, Panici, Pierluigi Benedetti, Venezia, Martina, Tomao, Silverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724566/
https://www.ncbi.nlm.nih.gov/pubmed/23901283
http://dx.doi.org/10.2147/OTT.S46301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724566/
https://www.ncbi.nlm.nih.gov/pubmed/23901283
http://dx.doi.org/10.2147/OTT.S46301

Ejemplares similares